Sqz Biotechnologies Co Alpha and Beta Analysis
SQZDelisted Stock | USD 0.10 0.04 28.57% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sqz Biotechnologies Co. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sqz Biotechnologies over a specified time horizon. Remember, high Sqz Biotechnologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sqz Biotechnologies' market risk premium analysis include:
Beta (0.37) | Alpha (1.94) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Sqz |
Sqz Biotechnologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sqz Biotechnologies market risk premium is the additional return an investor will receive from holding Sqz Biotechnologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sqz Biotechnologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sqz Biotechnologies' performance over market.α | -1.94 | β | -0.37 |
Sqz Biotechnologies Fundamentals Vs Peers
Comparing Sqz Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sqz Biotechnologies' direct or indirect competition across all of the common fundamentals between Sqz Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sqz Biotechnologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sqz Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Sqz Biotechnologies to competition |
Fundamentals | Sqz Biotechnologies | Peer Average |
Return On Equity | -1.05 | -0.31 |
Return On Asset | -0.33 | -0.14 |
Operating Margin | (3.92) % | (5.51) % |
Current Valuation | (6.5 M) | 16.62 B |
Shares Outstanding | 29.49 M | 571.82 M |
Shares Owned By Insiders | 3.12 % | 10.09 % |
Shares Owned By Institutions | 66.58 % | 39.21 % |
Sqz Biotechnologies Opportunities
Sqz Biotechnologies Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
Timeline |
1 | Sqz Bio earnings missed by 0.09, revenue fell short of estimates | 05/11/2023 |
About Sqz Biotechnologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sqz or other delisted stocks. Alpha measures the amount that position in Sqz Biotechnologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Sqz Biotechnologies Upcoming Company Events
As portrayed in its financial statements, the presentation of Sqz Biotechnologies' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sqz Biotechnologies' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sqz Biotechnologies' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sqz Biotechnologies. Please utilize our Beneish M Score to check the likelihood of Sqz Biotechnologies' management manipulating its earnings.
3rd of August 2023 Upcoming Quarterly Report | View | |
8th of November 2023 Next Financial Report | View | |
30th of June 2023 Next Fiscal Quarter End | View | |
27th of March 2024 Next Fiscal Year End | View | |
31st of March 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Sqz Biotechnologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |